ClinicalTrials.gg
Status unknownNCT04783610Updated Mar 5, 2021

Ethanol-induced Vestibular Dysfunction as a Model for Bilateral Vestibular Syndrome.

An interventional study of Ethanol in vHIT- and VOG-model for Bilateral Vestibular Neuronitis, sponsored by Turku University Hospital. Status unknown. Open to participants aged 22 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-03-05.

Sponsored by Turku University Hospital · Not applicable, Interventional, and Diagnostic

The sponsor has not verified this record recently (last verified Mar 2021), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
10
Allocation
Not applicable
Ages
22 Years and older
Sex
All
01

Study summary

The purpose of the study is to create a vHIT- and VOG-model for bilateral vestibular neuronitis, via ethanol administration in healthy human subjects.

Read the detailed description

Ethanol administration has an effect on vestibular function, measurable with video head impulse test (vHIT)- and vestibulo-oculography (VOG)-methods.

The purpose of the study is to create a vHIT- and VOG-model for bilateral vestibular neuronitis, a disease with difficult diagnostics, via ethanol administration in healthy human subjects.

As subjects are consuming ethanol via oral route, vHIT-measurements and VOG-measurements (slow and rapid eye movement recordings) are being recorded in order to measure the change in vestibular function.

During approx. 5 hours, 4 vHIT measurements will take place, while subjects ingest ethanol towards 1 per mille levels, measured via alcoholmeter.

Necessary precautions include strict exclusion criteria regarding health of the subjects and also comprehensive preparedness for management of allergic reactions and other unusual phenomena related to alcohol consumption.

02

Conditions studied

  • vHIT- and VOG-model for Bilateral Vestibular Neuronitis

Browse trials for

Keywords

  • vHIT
  • vestibular neuronitis
  • VOG
03

In context

Vestibular Neuronitis

34 studies on the registry are indexed under Vestibular Neuronitis; 4 are open to participants now.

This study's planned enrollment of 10 is below the median of 50 across 27 interventional studies indexed under Vestibular Neuronitis.

Browse Vestibular Neuronitis studies →

Lead sponsor

Turku University Hospital is the lead sponsor of 287 studies on the registry; 67 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
22 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • no previous ear diseases
  • normal hearing
  • no signs of alcohol dependence (6 points or less in AUDIT-questionnaire)

Exclusion criteria

Exclusion Criteria:

  • previous ear diseases
  • abnormal hearing
  • signs of alcohol dependence (7 points or more in AUDIT-questionnaire)
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
10 participants (estimated)

Study arms

  • Experimental
    Study subjects for vHIT- and VOG-measurements

    Each study subject is his/hers own comparator at different phases of ethanol consumption.

    Other: Ethanol

Interventions

  • OtherEthanol

    Ethanol will be administered via oral route.

06

What researchers measure

Primary outcomes

  1. Ethanol-induced vestibular function decline as measured with vHIT-gain-value-measurements.

    Video head impulse test measures the speed of eye movement as well as head movement (degrees per second, taken from 60 ms time interval from the beginning of head movement), the latter being produced by the investigator. The ratio of a sudden horizontal head movement and a rapid eye movement towards the opposite direction (as the subject is trying to fixate gaze straight ahead) is referred as gain value. With succeeding measurements during ethanol consumption, gain values will be recorded. The data contains vHIT gain -values at base level, without ethanol consumption, as well as during and after ethanol consumption. The most important tool in statistical analysis of the data is repeated measures analysis of variance (rm ANOVA). This allows each test subject to act as his/hers own control, as succeeding measurements are being compared to the base line values. The statistical significance will be set at the p\< 0.05 level.

    Time frame: 5 hours or 1 work day

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 5, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04783610
Responsible party
Jussi Sarin (Clinical Teacher in the Department of Otorhinolaryngology, Turku University Hospital) — Principal investigator
First posted
Mar 5, 2021
Start date
May 2021 (estimated)
Primary completion
Oct 2021 (estimated)
Completion
Oct 2021 (estimated)
Last update
Mar 5, 2021

Study contacts

Jussi Sarin, Ph.D.
Contact
jussar@utu.fi
+35823130409

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion